Assets of prescription digital therapeutics maker Pear Therapeutics have been broken up and sold at auction for $6.05 million after the company filed for bankruptcy in April.According to the court filing, Pear’s assets were…
Continue Reading
Cerebral already uses AI for patient-clinician pairing and detecting suicidal messages. In David Mou’s assessment, using AI for documentation could save up to 70% of clinicians’ time, allowing them more face-to-face time with patients….
Continue Reading
By Anuja Vaidya
May 18, 2023 – In a Frequently Asked Questions (FAQs) document, the Centers for Medicare and Medicaid Services (CMS) stated that hospitals could continue to bill for various outpatient therapies delivered via remote…
Continue Reading
Benefits navigation platform HealthJoy has expanded its partnership with virtual care company Teladoc to offer virtual primary care services to HealthJoy’s clients, the companies announced Thursday.
Chicago-based HealthJoy serves employers, brokers and third party administrators…
Roundup summary of recent digital health strategic partnerships:HealthJoy, Teladoc Health Launch Virtual Primary CareHealthJoy, a benefits navigation platform that amplifies employer benefit strategies expands its partnership with Teladoc Health to introduce virtual primary care….
Continue Reading
Chicago-based digital employee benefits platform HealthJoy is expanding its partnership with virtual care provider Teladoc Health to include virtual primary care services. HealthJoy offers benefits navigation to employers as well as virtual services for chronic…
Continue Reading
The following is a guest article by Yishai Knobel, CEO at RxWare
From April 2020 to August 2021, the healthcare solutions company Indegene looked at approximately 7.9 million emails sent by prescription drug companies across…
The following is a guest article by Patrick Tarnowski, Chief Commercial Officer at OneStep
As many as 91% of patients who could benefit from physical therapy (PT) do not access care, and of those who…
GrayMatters Health, a medtech company based in Israel, has developed Prism for PTSD, a self-neuromodulation therapy. The company has identified what they describe as brain-mechanism-specific biomarkers for certain mental disorders. These involve combining fMRI…
Continue Reading
Researchers at the Harvard Wyss Institute have developed a new type of cell therapy for multiple sclerosis patients. The technique involves taking a blood sample from the patient being treated, isolating a sample of…
Continue Reading
